Skip to content

Progyny PGNY Operating Income

Operating Income at other companies

CVS Health logo
CVS HealthCVS
$4.68B+38.7%
UnitedHealth Group logo
UnitedHealth GroupUNH
$8.99B-1.4%
Natera, Inc. logo
Natera, Inc.NTRA
-$93.52M-18.1%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$41.66M+29.8%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$17.83M+870%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$7.42M+42.2%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
Enterprise value$1.98B-29.6%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's operating income?
Progyny (PGNY) reported operating income of $35.38M in Q1 2026.
How has Progyny's operating income changed year-over-year?
Progyny's operating income increased by 46.4% year-over-year, from $24.17M to $35.38M.
What is the long-term trend for Progyny's operating income?
Over 4 years (2021 to 2025), Progyny's operating income has grown at a 27.4% compound annual growth rate (CAGR), from $32.34M to $85.28M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.